SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T111. A total of 17 filers reported holding SAB BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $15,770 | -5.7% | 281,107 | 0.0% | 0.00% | – |
| Q4 2022 | $16,726 | -7.1% | 281,107 | 0.0% | 0.00% | – |
| Q3 2022 | $18,000 | -57.1% | 281,107 | 0.0% | 0.00% | – |
| Q2 2022 | $42,000 | -67.4% | 281,107 | 0.0% | 0.00% | – |
| Q1 2022 | $129,000 | -74.4% | 281,107 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $503,000 | – | 281,107 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LMR Partners LLP | 387,588 | $272,000 | 0.01% |
| Radcliffe Capital Management, L.P. | 38,927 | $27,000 | 0.00% |
| Shaolin Capital Management LLC | 662,699 | $41,000 | 0.00% |
| EQUITEC PROPRIETARY MARKETS, LLC | 45,000 | $3,000 | 0.00% |
| Yakira Capital Management, Inc. | 108,485 | $7,000 | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 1,621 | $0 | 0.00% |
| MARSHALL WACE, LLP | 247,576 | $173,000 | 0.00% |
| MORGAN STANLEY | 148,939 | $9,000 | 0.00% |
| Walleye Trading LLC | 15,505 | $1,000 | 0.00% |
| Citadel Advisors | 19,905 | $1,000 | 0.00% |